Abstract
Antiresorptive drugs are widely used to prevent osteoporotic fractures in men and women. Large clinical trials have shown vertebral fracture risk reductions up to 50%, resulting from relatively small increases of 3–8% in bone mineral density (BMD). We developed a computer model that mimics bone turnover in human vertebral cancellous bone during menopause and antiresorptive treatment. This model links cell activity in trabeculae to changes in bone volume and mechanical properties. We asked whether treatment started shortly after menopause is better than treatment started late after menopause. In order to answer this question we used the model to simulate menopause and 5 years of anti-resorptive treatment with two different agents: one incorporated in the tissue, one not incorporated. We found that late treatment can result in almost the same bone mass as early treatment, but early treatment is much better in conserving the strength and stiffness of the cancellous bone. The effect of the incorporation of drugs in the tissue (giving the drugs a long half-life) was small. After discontinuation of treatment, bone was lost slower, but after 20 years the difference between the incorporated and the not incorporated drug in stiffness and bone volume was below 3%. This kind of simulation model may be used to preclinically test new pharmaceuticals and treatment protocols and to predict long-term effects of treatment before patient data become available.
Similar content being viewed by others
References
FP Coxon MH Helfrich R Van’t Hof S Sebti SH Ralston A Hamilton MJ Rogers (2000) ArticleTitleProtein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298. J Bone Miner Res 15 1467–1476 Occurrence Handle1:CAS:528:DC%2BD3cXlvVSjsLw%3D Occurrence Handle10.1359/jbmr.2000.15.8.1467 Occurrence Handle10934645
DJ Rowe LA Etre MJ Lovdahl DJ Pietrzyk (1999) ArticleTitleRelationship between bisphosphonate concentration and osteoclast activity and viability. Vitro Cell Dev Biol Anim 35 383–388 Occurrence Handle1:CAS:528:DyaK1MXls1yjt7w%3D Occurrence Handle10.1007/s11626-999-0112-7
S Vedi JE Compston (1996) ArticleTitleThe effects of long-term hormone replacement therapy on bone remodeling in postmenopausal women. Bone 19 535–539 Occurrence Handle1:CAS:528:DyaK28XnsVaktLw%3D Occurrence Handle10.1016/S8756-3282(96)00227-X Occurrence Handle8922654
B Ettinger DM Black BH Mitlak RK Knickerbocker T Nickelsen HK Genant C Christiansen PD Delmas JR Zanchetta J Stakkestad CC Gluer K Krueger FJ Cohen S Eckert KE Ensrud LV Avioli P Lips SR Cummings (1999) ArticleTitleReduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. JAMA 282 IssueID22 2124 Occurrence Handle10.1001/jama.282.22.2124
RP Tonino PJ Meunier R Emkey JA Rodriguez-Portales CJ Menkes RD Wasnich HG Bone AC Santora M Wu R Desai PD Ross (2000) ArticleTitleSkeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group. J Clin Endocrinol Metab 85 3109–3115 Occurrence Handle1:CAS:528:DC%2BD3cXmsVKru70%3D Occurrence Handle10999794
UA Liberman SR Weiss J Broll HW Minne H Quan NH Bell J Rodriguez-Portales RW Downs Jr J Dequeker M Favus (1995) ArticleTitleEffect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333 1437–1443 Occurrence Handle1:CAS:528:DyaK28XkslehtA%3D%3D Occurrence Handle10.1056/NEJM199511303332201 Occurrence Handle7477143
DM Black DE Thompson DC Bauer K Ensrud T Musliner MC Hochberg MC Nevitt S Suryawanshi SR Cummings (2000) ArticleTitleFracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. J Clin Endocrinol Metab 85 4118–4124 Occurrence Handle1:CAS:528:DC%2BD3cXotlWnurw%3D Occurrence Handle10.1210/jcem.85.11.6953 Occurrence Handle11095442
J Reginster HW Minne OH Sorensen M Hooper C Roux ML Brandi B Lund D Ethgen S Pack I Roumagnac R Eastell (2000) ArticleTitleRandomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group. Osteoporos Int 11 83–91 Occurrence Handle1:CAS:528:DC%2BD3cXhvFGgsr0%3D Occurrence Handle10.1007/s001980050010 Occurrence Handle10663363
HA Pols D Felsenberg DA Hanley J Stepan M Munoz-Torres TJ Wilkin G Qin-sheng AM Galich K Vandormael AJ Yates B Stych (1999) ArticleTitleMultinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study. Foxamax International Trial Study Group. Osteoporos Int 9 461–468 Occurrence Handle1:CAS:528:DyaK1MXkt1CktrY%3D Occurrence Handle10.1007/PL00004171 Occurrence Handle10550467
SR Cummings DB Karpf F Harris HK Genant K Ensrud AZ LaCroix DM Black (2002) ArticleTitleImprovement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 112 281–289 Occurrence Handle1:CAS:528:DC%2BD38XhvVWkurk%3D Occurrence Handle10.1016/S0002-9343(01)01124-X Occurrence Handle11893367
BL Riggs LJ Melton (1995) Osteoporosis: etiology, diagnosis, and treatment, 2nd ed. Lippincott-Raven Hagerstown, MD, USA
JC van der Linden JAN Verhaar H Weinans (2001) ArticleTitleA three-dimensional simulation of age-related remodeling in trabecular bone. J Bone Miner Res 16 688–696 Occurrence Handle1:STN:280:DC%2BD3MvlvFKqsg%3D%3D Occurrence Handle10.1359/jbmr.2001.16.4.688 Occurrence Handle11315996
S Tayyar PS Weinhold RA Butler JC Woodard LD Zardiackas KR St. John JM Bledsoe JA Gilbert (1999) ArticleTitleComputer simulation of trabecular remodeling using a simplified structural model. Bone 25 733–739 Occurrence Handle1:STN:280:DC%2BD3c%2FlvV2qsA%3D%3D Occurrence Handle10.1016/S8756-3282(99)00218-5 Occurrence Handle10593419
JS Thomsen L Mosekilde RW Boyce E Mosekilde (1994) ArticleTitleStochastic simulation of vertebral trabecular bone remodeling. Bone 15 655–666 Occurrence Handle1:STN:280:DyaK2M7nvVahsg%3D%3D Occurrence Handle10.1016/8756-3282(94)90314-X Occurrence Handle7873294
R Huiskes R Ruimerman GH van Lenthe JD Janssen (2000) ArticleTitleEffects of mechanical forces on maintenance and adaptation of form in trabecular bone. Nature 405 704–706 Occurrence Handle1:CAS:528:DC%2BD3cXktlGnsbo%3D Occurrence Handle10.1038/35015116 Occurrence Handle10864330
J Reeve (1986) ArticleTitleA stochastic analysis of iliac trabecular bone dynamics. Clin Orthop 213 264–278 Occurrence Handle3780102
P Garnero E Sornay-Rendu MC Chapuy PD Delmas (1996) ArticleTitleIncreased bone turnover in late postmenopausal women is a major determinant of osteoporosis. J Bone Miner Res 11 337–349 Occurrence Handle1:CAS:528:DyaK28Xit1Cgu74%3D Occurrence Handle10.1002/jbmr.5650110307 Occurrence Handle8852944
PR Ebeling LM Atley JR Guthrie HG Burger L Dennerstein JL Hopper JD Wark (1996) ArticleTitleBone turnover markers and bone density across the menopausal transition. J Clin Endocrinol Metab 81 3366–3371 Occurrence Handle1:CAS:528:DyaK28Xls1OrtLk%3D Occurrence Handle8784098
R Recker J Lappe K Davies R Heaney (2000) ArticleTitleCharacterization of perimenopausal bone loss: a prospective study. J Bone Miner Res 15 1965–1973 Occurrence Handle1:STN:280:DC%2BD3cvnslSkuw%3D%3D Occurrence Handle10.1359/jbmr.2000.15.10.1965 Occurrence Handle11028449
RP Heaney RR Recker PD Saville (1978) ArticleTitleMenopausal changes in bone remodeling. J Lab Clin Med 92 964–970 Occurrence Handle1:STN:280:DyaE1M7htVOqtA%3D%3D Occurrence Handle739174
R Eastell PD Delmas SF Hodgson EF Eriksen KG Mann BL Riggs (1988) ArticleTitleBone formation rate in older normal women: concurrent assessment with bone histomorphometry, calcium kinetics, and biochemical markers. J Clin Endocrinol Metab 67 741–748 Occurrence Handle1:CAS:528:DyaL1cXlvVOrurc%3D Occurrence Handle10.1210/jcem-67-4-741 Occurrence Handle3262119
ZH Han S Palnitkar DS Rao D Nelson AM Parfitt (1997) ArticleTitleEffects of ethnicity and age or menopause on the remodeling and turnover of iliac bone: implications for mechanisms of bone loss. J Bone Miner Res 12 498–508 Occurrence Handle1:STN:280:DyaK2s3ls1Sgsg%3D%3D Occurrence Handle10.1359/jbmr.1997.12.4.498 Occurrence Handle9101361
H Okano H Mizunuma M Soda I Kagami S Miyamoto M Ohsawa Y Ibuki M Shiraki T Suzuki H Shibata (1998) ArticleTitleThe long-term effect of menopause on postmenopausal bone loss in Japanese women: results from a prospective study. J Bone Miner Res 13 303–309 Occurrence Handle1:STN:280:DyaK1c7lsV2isQ%3D%3D Occurrence Handle10.1359/jbmr.1998.13.2.303 Occurrence Handle9495525
G Mazzuoli M Acca D Pisani D Diacinti A Scarda L Scarnecchia MT Pacitti E D’Erasmo S Minisola G Bianchi G Manfredi (2000) ArticleTitleAnnual skeletal balance and metabolic bone marker changes in healthy early postmenopausal women: results of a prospective study. Bone 26 381–386 Occurrence Handle1:STN:280:DC%2BD3c7osFelsA%3D%3D Occurrence Handle10.1016/S8756-3282(00)00242-8 Occurrence Handle10719282
JR Guthrie PR Ebeling JL Hopper E Barrett-Connor L Dennerstein EC Dudley HG Burger JD Wark (1998) ArticleTitleA prospective study of bone loss in menopausal Australian-born women. Osteoporos Int 8 282–290 Occurrence Handle1:STN:280:DyaK1M%2FhsVKnug%3D%3D Occurrence Handle10.1007/s001980050066 Occurrence Handle9797914
JM Pouilles F Tremollieres C Ribot (1993) ArticleTitleThe effects of menopause on longitudinal bone loss from the spine. Calcif Tissue Int 52 340–343 Occurrence Handle1:STN:280:DyaK3s3nvVKitA%3D%3D Occurrence Handle10.1007/BF00310195 Occurrence Handle8504369
M Sato W Grasser N Endo R Akins H Simmons DD Thompson E Golub GA Rodan (1991) ArticleTitleBisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest 88 2095–2105 Occurrence Handle1:CAS:528:DyaK38XjsVGgtA%3D%3D Occurrence Handle10.1172/JCI115539 Occurrence Handle1661297 Occurrence Handle295810
JE Compston PI Croucher (1991) ArticleTitleHistomorphometric assessment of trabecular bone remodelling in osteoporosis. Bone Miner 14 91–102 Occurrence Handle1:STN:280:DyaK38%2FgsVajsA%3D%3D Occurrence Handle10.1016/0169-6009(91)90086-F Occurrence Handle1912765
HM Frost (1985) ArticleTitleThe pathomechanics of osteoporoses. Clin Orthop 200 198–225 Occurrence Handle3905111
AM Parfitt (1983) The psychiological and clinical significance of bone histomorphometric data. Bone histomorphometry: techniques and interpretation. CRC Press Boca Raton, FL 143–223
FJ Hou SM Lang SJ Hoshaw DA Reimann DP Fyhrie (1998) ArticleTitleHuman vertebral body apparent and hard tissue stiffness. J Biomech 31 1009–1015 Occurrence Handle1:STN:280:DyaK1M%2FpsVKltA%3D%3D Occurrence Handle10.1016/S0021-9290(98)00110-9 Occurrence Handle9880057
B Van Rietbergen A Odgaard J Kabel R Huiskes (1996) ArticleTitleDirect mechanics assessment of elastic symmetries and properties of trabecular bone architecture. J Biomech 29 1653–1657 Occurrence Handle1:STN:280:DyaK2s7gtFWnsw%3D%3D Occurrence Handle10.1016/S0021-9290(96)80021-2 Occurrence Handle8945668
JC Gallagher D Goldgar A Moy (1987) ArticleTitleTotal bone calcium in normal women: effect of age and menopause status. J Bone Miner Res 2 491–496 Occurrence Handle1:STN:280:DyaL1czjvVensw%3D%3D Occurrence Handle10.1002/jbmr.5650020605 Occurrence Handle3455633
JJ Stepan J Pospichal J Presl V Pacovsky (1987) ArticleTitleBone loss and biochemical indices of bone remodeling in surgically induced postmenopausal women. Bone 8 279–284 Occurrence Handle1:STN:280:DyaL1c7gslWqtg%3D%3D Occurrence Handle10.1016/8756-3282(87)90002-0 Occurrence Handle3501301
I Fogelman C Ribot R Smith D Ethgen E Sod JY Reginster (2000) ArticleTitleRisedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. BMD-MN Study Group. J Clin Endocrinol Metab 85 1895–1900 Occurrence Handle1:CAS:528:DC%2BD3cXlt1Wlsb4%3D Occurrence Handle10843171
GY Boivin PM Chavassieux AC Santora J Yates PJ Meunier (2000) ArticleTitleAlendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women. Bone 27 687–694 Occurrence Handle1:CAS:528:DC%2BD3cXosFygtL8%3D Occurrence Handle10.1016/S8756-3282(00)00376-8 Occurrence Handle11062357
CP Jerome (1989) ArticleTitleEstimation of the bone mineral density variation associated with changes in turnover rate. Calcif Tissue Int 44 406–410 Occurrence Handle1:STN:280:DyaL1MzltlOrsw%3D%3D Occurrence Handle10.1007/BF02555969 Occurrence Handle2504453
JD Currey (1984) ArticleTitleEffects of differences in mineralization on the mechanical properties of bone. Philos Trans R Soc Lond B Biol Sci 304 509–518 Occurrence Handle1:STN:280:DyaL2c7ksFWnug%3D%3D Occurrence Handle10.1098/rstb.1984.0042 Occurrence Handle6142490
L Mosekilde (1989) ArticleTitleSex differences in age-related loss of vertebral trabecular bone mass and structure—biomechanical consequences. Bone 10 425–432 Occurrence Handle1:STN:280:DyaK3c7ms12ntw%3D%3D Occurrence Handle10.1016/8756-3282(89)90074-4 Occurrence Handle2624823
RW McCalden JA McGeough CM Court-Brown (1997) ArticleTitleAge-related changes in the compressive strength of cancellous bone. The relative importance of changes in density and trabecular architecture. J Bone Joint Surg Am 79 421–427 Occurrence Handle1:STN:280:DyaK2s3itl2msA%3D%3D Occurrence Handle9070533
JD Ringe H Faber A Dorst (2001) ArticleTitleAlendronate treatment of established primary osteoporosis in men: results of a 2-year prospective study. J Clin Endocrinol Metab 86 5252–5255 Occurrence Handle1:CAS:528:DC%2BD3MXos1Kqs7c%3D Occurrence Handle10.1210/jcem.86.11.7988 Occurrence Handle11701687
M Mullender B van Rietbergen P Ruegsegger R Huiskes (1998) ArticleTitleEffect of mechanical set point of bone cells on mechanical control of trabecular bone architecture. Bone 22 125–131 Occurrence Handle1:STN:280:DyaK1c7js1WjsA%3D%3D Occurrence Handle10.1016/S8756-3282(97)00251-2 Occurrence Handle9477235
RP Heaney (1994) ArticleTitleThe bone-remodeling transient: implications for the interpretation of clinical studies of bone mass change. J Bone Miner Res 9 1515–1523 Occurrence Handle1:STN:280:DyaK2M7hslGmsQ%3D%3D Occurrence Handle10.1002/jbmr.5650091003 Occurrence Handle7817796
Z Tabor E Rokita (2002) ArticleTitleStochastic simulations of remodeling applied to a two-dimensional trabecular bone structure. Bone 31 413–417 Occurrence Handle1:STN:280:DC%2BD38vntVCrtA%3D%3D Occurrence Handle10.1016/S8756-3282(02)00837-2 Occurrence Handle12231415
CJ Hernandez GS Beaupre R Marcus DR Carter (2001) ArticleTitleA theoretical analysis of the contributions of remodeling space, mineralization, and bone balance to changes in bone mineral density during alendronate treatment. Bone 29 511–516 Occurrence Handle1:CAS:528:DC%2BD3MXos1Kntrw%3D Occurrence Handle10.1016/S8756-3282(01)00613-5 Occurrence Handle11728920
RP Heaney AJ Yates AC Santora (1997) ArticleTitleBisphosphonate effects and the bone remodeling transient. J Bone Miner Res 12 1143–1151 Occurrence Handle1:STN:280:DyaK2svgtlektg%3D%3D Occurrence Handle10.1359/jbmr.1997.12.8.1143 Occurrence Handle9258743
J Reeve (1987) ArticleTitleBone turnover and trabecular plate survival after artificial menopause. Br Med J (Clin Res Ed) 295 757–760 Occurrence Handle1:STN:280:DyaL1c%2FltFKksQ%3D%3D Occurrence Handle10.1136/bmj.295.6601.757
FA TremoIlieres JM Pouilles C Ribot (2001) ArticleTitleWithdrawal of hormone replacement therapy is associated with significant vertebral bone loss in postmenopausal women. Osteoporos Int 12 385–390 Occurrence Handle10.1007/s001980170107
B Orr-Walker DJ Wattie MC Evans IR Reid (1997) ArticleTitleEffects of prolonged bisphosphonate therapy and its discontinuation on bone mineral density in post-menopausal osteoporosis. Clin Endocrinol (Oxf) 46 87–92 Occurrence Handle1:CAS:528:DyaK2sXhslOgsbc%3D Occurrence Handle10.1046/j.1365-2265.1997.d01-1741.x
JL Stock NH Bell CH Chesnut KE Ensrud HK Genant ST Harris MR McClung FR Singer RA Yood S Pryor-Tillotson L Wei AC Santora (1997) ArticleTitleIncrements in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal women. Am J Med 103 291–297 Occurrence Handle1:STN:280:DyaK1c%2Fis1Cntw%3D%3D Occurrence Handle10.1016/S0002-9343(97)00130-7 Occurrence Handle9382121
BJ Riis J Ise T von Stein Y Bagger C Christiansen (2001) ArticleTitleIbandronate: a comparison of oral daily dosing versus intermittent dosing in postmenopausal osteoporosis. J Bone Miner Res 16 1871–1878 Occurrence Handle1:CAS:528:DC%2BD3MXnsVKqtLo%3D Occurrence Handle10.1359/jbmr.2001.16.10.1871 Occurrence Handle11585352
Acknowledgements
J.C. van der Linden was supported by the Dutch Foundation for Research (NWO/MW), the National Computing Facilities Foundation (NCF) provided computing time. The authors thank Prof. Ruegsegger for providing the CT-scan data from the European Union project “Assessment of bone quality in osteoporosis.”
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
van der Linden, J., Verhaar, J., Pols, H. et al. A Simulation Model at Trabecular Level to Predict Effects of Antiresorptive Treatment after Menopause . Calcif Tissue Int 73, 537–544 (2003). https://doi.org/10.1007/s00223-002-2151-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-002-2151-x